The purpose of this study is to evaluate the use of the iFuse Implant System to treat degenerative sacroiliitis (arthritis of the SI joint) and sacroiliac disruption (abnormal separation or tearing of the sacroiliac joint). The iFuse Implant System (iFuse device) is a medical device that is surgically implanted into the sacroiliac (SI) joint during a minimally invasive surgical procedure (one that uses a smaller incision and less damage to the skin and other tissues than standard surgery). The purpose of implanting the device is to stabilize and fuse the SI joint.
The 12 month interim study results from the SIFI clinical trial, which evaluates the safety and effectiveness of the iFuse Implant System®, were published in the Global Spine Journal. We invite you to read the article for yourself here.
This study is not enrolling patients at this time.